Find Practice Guidelines
The HIV Medicine Association is an organization of medical professionals who practice HIV medicine. We represent the interests of our patients by promoting quality in HIV care and by advocating for policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice.
IDSA, ASM, and PASCV Letter to FDA on LDTs (PDF)
IDSA, the American Society for Microbiology (ASM), and the Pan American Society for Clinical Virology (PASCV) urge FDA to consider the vital role of lab developed tests (LDTs) in rapidly diagnosing and appropriately treating infectious diseases.
PACCARB Press Release
Recommendations from the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria reflect IDSA input.
IDSA & HIVMA Engage HHS on Drug Pricing and Innovation
IDSA and HIVMA wrote to HHS Secretary Burwell to distinguish efforts to incentivize development of desperately needed new drugs from recent actions to significantly increase the costs of decades old drugs.
IDSA Writes to Senate Aging Committee Ahead of Hearing on Drug Pricing Spikes
IDSA wrote to the Senate Special Committee on Aging ahead of a planned hearing on recent drug price spikes. The IDSA letter distinguished efforts to incentivize development of desperately needed new drugs from recent actions to significantly increase the costs of decades old drugs.
IDSA Leads Stakeholders In Support of R&D Tax Credit for Antibiotics and Rapid Diagnostics
Forty groups representing providers, patients, public health and industry joined a letter – circulated by IDSA – supporting the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539.
IDSA Statement: White House Antibiotic Stewardship Forum
At this week’s White House Forum on Stewardship, IDSA President Steve Calderwood, MD, FIDSA said, “Our expertise on diagnosing and treating patients with serious infectious diseases makes us particularly well suited to lead multi-disciplinary institution-level stewardship programs that will improve patient outcomes”
Senators Urged to Support Antibiotic R&D Bill
A bill to establish a new FDA approval pathway for antibacterial drugs to treat life-threatening infections where there exists an unmet medical need has been introduced in the Senate. IDSA members asked to engage their Senators.
IDSA Spearheads Advocacy Effort for AR Funding
IDSA was joined by 56 groups in a letter to congressional appropriators calling for funding to address antimicrobial resistance.
1 of 8
FDA Evaluating Study Examining Use of Oral Fluconazole (Diflucan) in Pregnancy
CDC and OSHA Issue Interim Guidance for Protecting Workers from Occupational Exposure to Zika Virus
CDC concludes Zika causes microcephaly and other birth defects
Focus Diagnostics Laboratory Examination Kits: Class I Recall - Inaccurate Test Results
National Zika Summit Focused on Coordinated U.S. Response
CDC issues interim guidance for the safe care of survivors of Ebola Virus Disease
Preventing Transmission of Zika Virus in Labor and Delivery Settings Through Implementation of Standard Precautions
FDA approves new treatment for inhalation anthrax
From the PresidentIDSA and SHEA Release New Guideline on Antibiotic StewardshipIDSA Adopts All-In Match PolicyIDWeek Mentorship ProgramJournal Club
>> Read More
The Society’s next top staffer brings extensive experience in association management and has a track record for organizational leadership representing healthcare professionals.
The new IDSA guidelines on Implementing an Antimicrobial Stewardship Program focus on specific strategies that the evidence suggests are most beneficial to ensure the program will be effective and sustainable.
A new study in CID suggests seasonal flu vaccination during pregnancy may guard against stillbirth.
From the PresidentIDWeek 2016Call for Committee VolunteersPresident's Budget RequestJournal Club
The latest release of the guidance reflects several important developments, including the recent approval of the second single-tablet fixed dose combination regimen (elbasvir/grazoprevir) for the treatment of HCV.
From the PresidentZika VirusNext Editor of CIDNominate Your ColleagueJournal Club
1 of 7
| IDSA | Contact Us
© Copyright HIVMA 2016 HIV Medicine Association